Objectives : This research is to test anti-cancer effect of kyungohkgo (sample 1) and modified kyungohkgoes (sample 2 and sample 3) when they prescribed to mice that translate a 3LL lung cancer cell. A sample 1, 2, and 3 are prescribed for the 1st, 2nd and 3rd group, respectively.
Methods : Inoculate mouse lung carcinoma cells to a BDFI mouse and did an experiment about tumor occurrence periods, body weight, tumor volume, survival rate, life prolongation.
Results : The development time of tumor lump to the 3rd group is latest as 181.71±18.88 hours. That is, it means that a lung cancer of this group was induced latest. In tumor size, the 3rd group is also fewest by 1,536~9,375㎣. The tumor growth rate of the 3rd group appeared lowest by 610.35 percent. Only the 3rd group was appeared that has a control effect of tumor growth. Also, 3 mice of the 3rd group were survived for 30day after translating the lung cancer cells. The survival extension rate of the 3rd group was highest by 38.39 percent.
Conclusion : In these experiments, it appears that the sample 3 prescribed by modified kyungohkgo has the highest anti-cancer effect. It is proved that the modified kyungohkgo affects the 3LL lung cancer cell by acting complexly.
|